Delayed deformation of self-expanding stents after carotid artery stenting for postendarterectomy restenoses  by Yallampalli, Sasidhar et al.
From the Southern Association for Vascular Surgery
Delayed deformation of self-expanding
stents after carotid artery stenting for
postendarterectomy restenoses
Sasidhar Yallampalli, BS, Wei Zhou, MD, Peter H. Lin, MD, Ruth L. Bush, MD,
and Alan B. Lumsden, MD, Houston, Tex
Carotid artery stenting has become an acceptable alternative for treating patients with severe atherosclerotic lesions,
particularly those with significant surgical risks, such as recurrent stenosis after endarterectomy. Stent deformation, a
phenomenon primarily associated with balloon-expandable stents, is largely avoided by exclusively using self-expanding
stents in treating carotid artery stenosis. Nonetheless, we herein report two patients who presented with delayed
Wallstent deformation after carotid artery stenting for postendarterectomy restenosis. Our cases highlight the need for
caution because delayed deformation of self-expanding stents can occur, particularly during treatment of patients with
postendarterectomy stenosis. Furthermore, poststent surveillance is imperative in identifying patients with severe
restenosis after carotid artery stenting who need reintervention. (J Vasc Surg 2006;44:412-5.)Since DeBakey performed the first successful carotid
artery endarterectomy (CEA) in 1953, CEA has become
the gold standard for treating patients with high-grade
carotid stenoses.1,2 However, this technique is not without
complications: infection, stroke, hemorrhage, and cranial
nerve injuries have been reported after CEA.3 Further-
more, increased risks have been demonstrated in the sub-
groups of patients with significant medical comorbidities
and difficult surgical anatomies, such as recurrent stenosis
after endarterectomy, prior neck irradiation, and inaccessi-
ble lesions above the C2 level.4-6 Therefore, carotid artery
stenting (CAS) has evolved as a valuable alternative to
CEA, particularly in high-risk patients. Although the field
of carotid stenting is rapidly advancing and its efficacy has
been proven in multiple clinical trials, we herein relate the
need for caution when treating post-CEA restenosis, be-
cause deformation of self-expanding Wallstents (Boston
Scientific, Natick, Mass) occurred in two of our patients.
CASE REPORTS
Patient 1. A 64-year-old man with a history of right CEA with
patch angioplasty for a high-grade carotid artery stenosis presented
with recurrent symptoms 6 months later. Duplex ultrasonography
revealed severe recurrent stenosis, which was successfully treated with
a Wallstent placement. A completion angiogram showed a resolution
of stenosis with a brisk antegrade flow. However, increased internal
carotid artery (ICA) velocities with a significant color-flow distur-
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412bance consistent with significant in-stent restenosis were detected 3
and 6 months later on follow-up duplex ultrasound scans (369 peak
systolic/147 end diastolic cm/s and 513 peak systolic/151 end
diastolic cm/s, respectively). Each stenosis was confirmed by an
angiogram (Fig 1, A) and was respectively treated with a cutting
balloon angioplasty at 3 months and a cutting balloon angioplasty
with, subsequently, a second Wallstent placement at 6 months. The
patient again presented with several episodes of right hemisphere
transient ischemic attacks 3 months afterward. An ultrasound evalua-
tion revealed an increased peak systolic velocity of 434 cm/s, an
end-diastolic velocity of 212 cm/s, and a severe color flow distur-
bance indicating a high-grade stenosis, which was confirmed by
an angiogram (Fig 1, B). The angiogram also showed a deformed
second Wallstent with a dilated proximal portion against the
patched carotid bulb and a significant narrowing of the distal end
located within the first stent that was flow limiting. We therefore
decided on an endovascular approach in treating this lesion.
After administration of intravenous bivalirudin, the right ca-
rotid artery was cannulated. A 7F, 90-cm carotid guiding sheath
(Boston Scientific) was placed in themid common carotid artery by
tracking over a 0.035-inch stiff Glidewire (Boston Scientific). A
selective digital carotid angiogram via the side port of the guiding
sheath confirmed the severe stenosis due to stent deformation and
a patent intracranial ICA. A Filterwire (Boston Scientific) emboli-
zation protection device was then manipulated to cross the lesion.
After activation of the embolization protection device, a third
Wallstent was deployed across the stenosis and dilated with a
5-mm-diameter angioplasty balloon.With satisfactory angiographic
results, the embolization protection device was then captured and
the shuttle sheath subsequently removed (Fig 1, C). The patient
was discharged home the next day after an uneventful hospital stay.
He remains symptom free 6 months later with good stent apposi-
tion.
Patient 2. A 72-year-old man underwent left CEA with a
patch angioplasty for symptomatic carotid artery stenosis 4 years
ago. The patient presented with amaurosis fugax and recurrent
high-grade stenosis at the proximal end of the patch (Fig 2, A) that
required a repeat CEA 1 year later and subsequent CAS with a
men.
JOURNAL OF VASCULAR SURGERY
Volume 44, Number 2 Yallampalli et al 413Wallstent 3 years later (Fig 2, B). He again presented with symp-
toms of transient ischemic attack 1 year after the CAS with an
ultrasound scan indicating severe stenosis (velocity ratio of ICA/
common carotid artery 4). A magnetic resonance image illus-
trated a high-grade recurrent stenosis, and a carotid angiogram
Fig 1. A, Severe in-stent restenosis demonstrated on
postendarterectomy restenosis. B, Angiogram 3 months
Wallstent with a dilated proximal portion against the patc
located within the first stent that was flow limiting.C, Co
the lesion, showing good antegrade flow and a patent lu
Fig 2. A, Recurrent high-grade stenosis at the proximal end of
the patch 4 years after carotid artery endarterectomy (CEA) with
patch angioplasty. B, Completion angiogram after stenting for
post-CEA restenosis showing good carotid stent position with
brisk antegrade flow.showed a deformed stent with a widened middle portion apposedto the patched carotid bulb and a significantly narrowed distal end
located in the native ICA, which substantially limited ICA blood
flow (Fig 3, A). To relieve his symptoms and repair the deformed
stent, an endovascular approach was chosen.
As described previously, after systemic anticoagulation was
initiated, a guidewire was used to cannulate the left carotid artery.
However, the tip of the wire was bounced against the extremely
narrowed stent opening, thus forming a J-shaped curve, which
potentially protected the wire from penetrating through the struts
of the stent. A selective catheter was then advanced over the wire to
the narrowed stent opening, and the wire was carefully manipu-
lated through the opening. Next, the distal end of the stent was
dilated with an angioplasty balloon, followed by a short Express
stent (Boston Scientific) for further support. The completion
angiogram showed a patent stent with a brisk antegrade flow
(Fig 3, B). The patient recovered well from the procedure and
remained symptom free 1 year later. Furthermore, the stent was
patent on a follow-up ultrasound evaluation.
DISCUSSION
CAS has become an acceptable alternative in treating
high-grade carotid artery stenoses, particularly in high-risk
patients. Stent deformation, a phenomenon primarily associ-
ated with balloon-expandable stents, often results in throm-
bosis and symptom recurrence. Therefore, self-expanding
stents with increased flexibility and a radial expanding force
have been exclusively used for treating carotid artery steno-
sis to avoid the occurrence of stent deformation. However,
the cases described herein emphasize the potential risk of
ngiogram 6 months after carotid artery stenting for
econd Wallstent placement showing a deformed second
arotid bulb and a significant narrowing of the distal end
tion angiogram after the third Wallstent deployed acrossan a
after s
hed c
mpledeformation of self-expanding stents, particularly in treat-
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tance of poststent surveillance in identifying the patients
who require reintervention.
CEA, currently the gold standard for treating symp-
tomatic and asymptomatic carotid artery stenosis, was first
introduced in the 1950s. Since then, its efficacy has been
demonstrated by numerous clinical trials.1,2 However,
post-CEA restenosis withmore than 50% luminal reduction
has been documented at rates of 7% to 22% according to
duplex ultrasonography.3,7,8 Therefore, a patch angio-
plasty in combination with CEA has been widely adopted
for potentially improving surgical outcomes, as demon-
strated in several clinical investigations.8-10 Theoretically, a
patch angioplasty allows for an increased cross-sectional
diameter, thereby reducing the rate of restenosis. However,
as demonstrated in patient 2, the oversized patch causes a
significant size mismatch between the native ICA and the
patched carotid bulb, and this raises challenges for future
carotid stent selection and placement.
Despite the proven efficacy of CEA, significant cardio-
pulmonary morbidities and difficult surgical anatomies may
increase procedure-related complications in a subset of
patients undergoing CEA. Thus, CAS is advocated as a
valuable alternative to CEA, particularly among patients
with high surgical risks, such as postendarterectomy steno-
sis, an irradiated neck, surgically inaccessible high lesions,
or substantial cardiopulmonary morbidities.4-6 There are
still several ongoing multicenter prospective trials evaluat-
ing the efficacy of CAS. Meanwhile, the technology con-
tinues to evolve. The first generation of carotid stents
Fig 3. A, Carotid angiography 1 year after carotid artery stenting
demonstrating a deformed stent with a widened middle portion
apposed to the patched carotid bulb and a significantly narrowed
distal end located in the native internal carotid artery, which
substantially limited internal carotid artery blood flow. B, The
completion angiography after angioplasty and Express stent place-
ment showing a patent stent with a brisk antegrade flow.involved balloon-expandable stents. The Palmaz (Cordis,Johnson & Johnson International Systems, Warren, NJ)
stents have the advantage of accurate placement but have
decreased longitudinal flexibility and are plagued by reports
of stent deformation secondary to extrinsic compression of
the cervical carotid arteries that are not protected by bony
structures.11-13 Carotid stenting then moved to self-
expanding stents, which improved flexibility and the radial
expansion force, thereby increasing the resistance to defor-
mation. However, our cases, for the first time, to our
knowledge, demonstrate the deformation of self-expanding
stents (namely, Wallstents) in the treatment of carotid artery
stenosis in patients with post-CEA restenosis.
Among several theories, we speculate that a large lumi-
nal diameter mismatch, decreased compliance of the artery
after surgical intervention, and specific characteristics of the
stainless-steel Wallstent may encourage the deformation.
Both of our patients received carotid stenting for post-CEA
restenosis, with the proximal ends of the stents placed
within the patched common carotid arteries. A large cross-
section diameter discrepancy between a small ICA and a
large patched carotid bulb potentially causes an uneven
expansion of the stainless-steel stent, which can store elastic
energy. Theoretically, a stent that expands to a markedly
larger cross-sectional diameter at one end and a smaller
expansion at the other end does not have the same stability
as a stent that undergoes a uniform expansion. In addition,
the outward force of the expansion at the proximal end
of the larger diameter may induce an opposite inward force
at the smaller cross section of the distal end (because metal
generally transmits force evenly across its surface), thereby
leading to a Wallstent deformation and shortening. Fur-
thermore, poor compliance of operated carotid arteries due
to a surgery-induced fibrosis formation may further limit
the ability of the stent to expand. Finally, both of our
patients had aggressive myointimal hyperplasia, as demon-
strated by significant restenosis shortly after CEA and CAS.
This malignant myointimal hyperplasia may also contribute
to stent deformation by generating inward force at the site
of stenosis.
In conclusion, the deformation of self-expanding stents
is a rare complication in carotid stenting procedures. Al-
though we observed this phenomenon only withWallstent,
this complication may occur with other self-expanding
stents in treating post-CEA stenosis. Our cases emphasize
the need for caution during stenting of postsurgical carotid
arteries with marked diameter mismatches and underline
the need for diligent post-CAS surveillance in identifying
patients who require reintervention.
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